Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in MAIA — MAIA Biotechnology, Inc.

CIK 1107261 HOUSTON, TX
Back to MAIA Full portfolio

Position in MAIA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$109,440
+$59,040 QoQ
Shares Held
76,000
+111.1% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 36 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. MAIA ranks #95 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in MAIA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $109,440 76,000
2026-03-31 $50,400 36,000
2025-12-31 $55,080 36,000
2025-09-30 $55,440 36,000
2025-06-30 $64,800 36,000
2025-03-31 $55,080 36,000
2024-12-31 $90,486 45,700
2024-09-30 $128,417 45,700
2024-06-30 $156,294 45,700
2024-03-31 $100,540 45,700
2023-12-31 $88,569 75,700
2023-09-30 $113,520 51,600
2023-06-30 $58,520 26,600